Breast cancer risk and clinical implications for germline PTEN mutation carriers
Breast cancer risk and clinical implications for germline PTEN mutation carriers
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
PTEN
Hamartoma Tumor syndrome (PHTS) encompasses a clinical spectrum of heritable disorders including Cowden syndrome (CS), Bannayan–Riley–Ruvalcaba syndrome, and Proteus and Proteus-like syndrome that are associated with germline mutations in the
PTEN
tumor suppressor gene. Breast cancer risk estimates (67–85 %) for women with germline
Alternative Titles
Full title
Breast cancer risk and clinical implications for germline PTEN mutation carriers
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1859705180
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1859705180
Other Identifiers
ISSN
0167-6806
E-ISSN
1573-7217
DOI
10.1007/s10549-015-3665-z
